Moderna Finds ‘Robust Antibody Response’ in Omicron-Specific Booster

Take that, Omicron. Results of a trial looking at a combination COVID-19 vaccine booster reveals a “robust antibody response” against the Omicron variant, vaccine manufacturer Moderna announced Wednesday.